STREAMEX CORP. Sales-type Lease, Interest Income, Lease Receivable
STREAMEX CORP. (STEX) reported Sales-type Lease, Interest Income, Lease Receivable of $17.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Income Statement › Other Income
us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable · last filed 2025-08-15
- STREAMEX CORP. sales-type lease, interest income, lease receivable for the quarter ending 2023-12-31 was $1.00K, a 50.00% decline year-over-year.
- STREAMEX CORP. sales-type lease, interest income, lease receivable for the quarter ending 2023-09-30 was $2.00K.
- STREAMEX CORP. sales-type lease, interest income, lease receivable for the quarter ending 2023-06-30 was $0.00.
- STREAMEX CORP. sales-type lease, interest income, lease receivable for the quarter ending 2023-03-31 was $0.00.
- STREAMEX CORP. sales-type lease, interest income, lease receivable for fiscal 2023 was $3.00K, a 50.00% increase from fiscal 2022.
- STREAMEX CORP. sales-type lease, interest income, lease receivable for fiscal 2022 was $2.00K.
| Period end | Sales-type Lease, Interest Income, Lease Receivable 3 month | Sales-type Lease, Interest Income, Lease Receivable 6 month | Sales-type Lease, Interest Income, Lease Receivable 9 month | Sales-type Lease, Interest Income, Lease Receivable 12 month |
|---|---|---|---|---|
| 2025-06-30 | $17.00K 10-Q · filed 2025-08-15 | |||
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $3.00K derived: sum of 2 quarters · filed 2025-04-15 | $3.00K derived: sum of 3 quarters · filed 2025-04-15 | $3.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.00K derived: sum of 2 quarters · filed 2024-11-14 | $2.00K 10-Q · filed 2024-11-14 | $4.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $2.00K derived: sum of 3 quarters · filed 2024-04-16 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $2.00K derived: sum of 2 quarters · filed 2024-04-16 | ||
| 2022-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $2.00K 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |